Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: July 31, 2026 at 4:34 PM UTC
| NCT Number | NCT07492680 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE2 |
| Target Enrollment | 260 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | July 30, 2026 (Yesterday) |
As of July 31, 2026: Clinical trial NCT07492680 is currently recruiting participants. This phase2 study for solid tumors is actively seeking new participants at 16 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07492680 is actively recruiting participants as of July 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07492680 was last updated Yesterday (July 30, 2026). HelloStudys verifies this status automatically.